Mirtazapin AbZ

Mirtazapin AbZ may be available in the countries listed below.

Ingredient matches for Mirtazapin AbZ

Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapin AbZ in the following countries:

• Germany

International Drug Name Search

Atenolol A

Atenolol A may be available in the countries listed below.

Ingredient matches for Atenolol A

Atenolol

Atenolol is reported as an ingredient of Atenolol A in the following countries:

• Netherlands

International Drug Name Search

Floraqpharma

Floraqpharma may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Floraqpharma

Florfenicol

Florfenicol is reported as an ingredient of Floraqpharma in the following countries:

• Norway

International Drug Name Search

Triptizol

Triptizol may be available in the countries listed below.

Ingredient matches for Triptizol

Amitriptyline

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Triptizol in the following countries:

• Italy

International Drug Name Search

Nutrivit-E

Nutrivit-E may be available in the countries listed below.

Ingredient matches for Nutrivit-E

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Nutrivit-E in the following countries:

• Bangladesh

International Drug Name Search

Rescriptor

Generic Name: delavirdine (Oral route)

del-a-VIR-deen

Commonly used brand name(s)

In the U.S.

• Rescriptor

Available Dosage Forms:

• Tablet

Therapeutic Class: Antiretroviral Agent

Pharmacologic Class: Non-Nucleoside Reverse Transcriptase Inhibitor

Uses For Rescriptor

Delavirdine is used, in combination with other medicines, in the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS).

Delavirdine will not cure or prevent HIV infection or AIDS; however, it helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay the development of problems usually related to AIDS or HIV disease. Delavirdine will not keep you from spreading HIV to other people. People who receive this medicine may continue to have other problems usually related to AIDS or HIV disease.

This medicine is available only with your doctor's prescription.

Before Using Rescriptor

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Geriatric

Delavirdine has not been studied specifically in older people. Therefore, it is not known whether it causes different side effects or problems in the elderly than it does in younger adults.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Alprazolam


• Astemizole


• Cisapride


• Dihydroergotamine


• Ergonovine


• Ergotamine


• Fosamprenavir


• Fosphenytoin


• Methylergonovine


• Midazolam


• Phenytoin


• Pimozide


• Terfenadine


• Triazolam

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Amiodarone


• Bepridil


• Carbamazepine


• Cimetidine


• Clozapine


• Etravirine


• Famotidine


• Flecainide


• Ixabepilone


• Lansoprazole


• Lidocaine


• Lovastatin


• Nizatidine


• Omeprazole


• Phenobarbital


• Propafenone


• Quinidine


• Ranitidine


• Rifabutin


• Rifampin


• Rilpivirine


• Simvastatin


• St John's Wort


• Voriconazole

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Aluminum Carbonate, Basic


• Aluminum Hydroxide


• Aluminum Phosphate


• Amprenavir


• Cerivastatin


• Clarithromycin


• Dalfopristin


• Desogestrel


• Didanosine


• Dienogest


• Dihydroxyaluminum Aminoacetate


• Dihydroxyaluminum Sodium Carbonate


• Drospirenone


• Ergoloid Mesylates


• Estradiol Cypionate


• Estradiol Valerate


• Ethinyl Estradiol


• Ethynodiol Diacetate


• Etonogestrel


• Fluoxetine


• Indinavir


• Ketoconazole


• Lacidipine


• Lercanidipine


• Levonorgestrel


• Magaldrate


• Magnesium Carbonate


• Magnesium Hydroxide


• Magnesium Oxide


• Magnesium Trisilicate


• Manidipine


• Medroxyprogesterone Acetate


• Mestranol


• Nelfinavir


• Nilvadipine


• Nitrendipine


• Norelgestromin


• Norethindrone


• Norgestimate


• Norgestrel


• Quinupristin


• Rifapentine


• Ritonavir


• Saquinavir


• Sildenafil

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Achlorhydria (absence of stomach acid)—Delavirdine should be taken with an acidic beverage such as orange or cranberry juice

• Liver disease—Effects of delavirdine may be increased because of slower removal from the body

Proper Use of Rescriptor

This medicine can be taken with our without food.

It is very important that you find out about medicines that can not be taken with delavirdine.

It is best to swallow both the 100 milligram (mg) and 200 milligram (mg) tablets whole. However, if swallowing is difficult, the 100 milligram (mg) tablet can be put in a glass of water (at least 3 ounces), allowed to sit for a few minutes, and then stirred to mix. Drink the mixture right away. Then rinse the glass with water and drink that rinse to make sure the full dose is taken.

Note: Only the 100 milligram (mg) tablets can be put into a glass of water to dissolve. The 200 milligram (mg) tablets must be swallowed whole.

Do not take any antacid medications within 1 hour of the time you take delavirdine. They may prevent delavirdine from being absorbed into the body.

For patients with achlorhydria (absence of stomach acid) they should take delavirdine with a glass of orange juice or cranberry juice.

Take this medicine exactly as directed by your doctor. Do not take it more often, and do not take it for a longer time than your doctor ordered. Also, do not stop taking this medicine without checking with your doctor first.

Keep taking delavirdine for the full time of treatment, even if you begin to feel better.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For oral dosage form (tablets):
  
  • For treatment of HIV infection:
    
    • Adults—400 mg three times a day in combination with other antiretroviral medicines. Your healthcare professional will decide on the other medicines needed and how much you will use.
    
    
    • Children younger than 16 years of age—Use and dose must be determined by your doctor.
    
    
  
  

Missed Dose

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using Rescriptor

It is very important that your doctor check your progress at regular visits.

Rescriptor Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur:

More common

• Skin rash (severe) with itching

Less common

• Skin rash with symptoms such as fever, blistering, oral lesions, conjunctivitis, swelling, muscle aches, or joint aches

Rare

• Difficulty in breathing

Incidence unknown

• Agitation


• back, leg, or stomach pains


• bleeding gums


• chills


• coma


• confusion


• dark urine


• decreased urine output


• depression


• difficulty breathing


• dizziness


• fatigue


• fever


• general body swelling


• headache


• hostility


• irritability


• lethargy


• loss of appetite


• muscle twitching


• nausea


• nosebleeds


• pale skin


• rapid weight gain


• seizures (convulsions)


• sore throat


• stupor


• swelling of face, ankles, or hands


• unusual tiredness or weakness


• vomiting


• yellowing of the eyes or skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Body aches or pain


• cough


• diarrhea


• discouragement


• ear congestion


• fear


• feeling sad or empty


• general feeling of discomfort or illness


• joint pain


• lack or loss of strength


• loss of interest or pleasure


• loss of voice


• muscle aches and pains


• nasal congestion


• nervousness


• pain, localized


• pain or tenderness around eyes and cheekbones


• runny nose


• shivering


• shortness of breath


• sneezing


• sweating


• tightness in chest


• tiredness


• trouble concentrating


• trouble sleeping


• wheezing

Less common

• Abdominal pain, generalized


• dryness or soreness of throat


• hoarseness


• sleeplessness


• tender, swollen glands in neck


• trouble in swallowing


• unable to sleep


• voice changes

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Rescriptor side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Rescriptor resources

• Rescriptor Side Effects (in more detail)
• Rescriptor Dosage
• Rescriptor Use in Pregnancy & Breastfeeding
• Drug Images
• Rescriptor Drug Interactions
• Rescriptor Support Group
• 0 Reviews for Rescriptor - Add your own review/rating

• Rescriptor Prescribing Information (FDA)


• Rescriptor Concise Consumer Information (Cerner Multum)


• Rescriptor Monograph (AHFS DI)


• Rescriptor MedFacts Consumer Leaflet (Wolters Kluwer)

Compare Rescriptor with other medications

• HIV Infection

Oscimin SR Tablets

Generic Name: hyoscyamine sulfate

Dosage Form: tablet, extended release
Oscimin SR Tablets

DESCRIPTION

Each sustained-release tablet for oral administration contains:

Hyoscyamine Sulfate, USP …… 0.375 mg

Hyoscyamine sulfate is one of the principal anticholinergic/ antispasmodic components of belladonna alkaloids.

Figure 1: Hyoscyamine Sulfate

(C17H23NO3)2 • H2SO4 • 2H2O     M.W. = 712.85

INACTIVE INGREDIENTS

Inactive ingredients include: calcium phosphate dibasic, ethylcellulose, Green LKB #LB-620, lactose monohydrate, magnesium stearate (veg.), microcrystalline cellulose, and stearic acid.

CLINICAL PHARMACOLOGY

Hyoscyamine has actions similar to those of atropine, but is more potent in both its central and peripheral effects.

This product inhibits gastrointestinal propulsive motility and decreases gastric acid secretions. This product controls excessive pharyngeal, tracheal, and bronchial secretion.

Once absorbed, this product disappears rapidly from the blood and is distributed throughout the entire body. The majority of hyoscyamine sulfate is excreted in the urine unchanged within the first 12 hours and only traces of hyoscyamine sulfate are found in the breast milk.

INDICATIONS AND USAGE

This product may be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries and diverticulitis. It can also be used to control gastric secretion, visceral spasm and hypermotility in cystitis, pylorospasm and associated abdominal cramps. Along with appropriate analgesics, this product is indicated in symptomatic relief of biliary and renal colic and as a drying agent in the relief of symptoms of acute rhinitis.

This product is effective as adjunctive therapy in the treatment of peptic ulcer and irritable bowel syndrome, acute enterocolitis and other functional gastrointestinal disorders.

CONTRAINDICATIONS

Glaucoma, obstructive uropathy, obstructive diseases of the gastrointestinal tract, paralytic ileum, intestinal atony of elderly or debilitated patients, unstable cardiovascular status, severe ulcerative colitis, toxic megacolon, myasthenia gravis, and myocardial ischemia. This product is not recommended for use in children under twelve years of age.

WARNINGS

Heat prostration can occur with drug use in the event of high environmental temperature. Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy; in this instance, treatment would be inappropriate and possibly harmful. This product may cause drowsiness or blurred vision. Patients taking this product should be warned not to engage in activities requiring mental alertness such as operating a motor vehicle or other machinery or to perform hazardous tasks while taking this drug.

PRECAUTIONS

Use caution in patients with hiatal hernia associated with reflex esophagitis. Use extreme caution and only when needed in patients with autonomic neuropathy, hyperthyroidism, coronary heart disease, congestive heart failure and cardiac arrhythmia. Investigate any tachycardia before giving any anticholinergic drugs since they may increase the heart rate.

Prolonged use of anticholinergics may decrease or inhibit salivary flow, thus contributing to the development of caries, periodontal disease, oral candidiasis, and discomfort.

Information for Patients

This medication should be taken 30 minutes to one hour before meals. This medication should be used with caution during exercise or hot weather; overheating may result in heat stroke. Hyoscyamine may cause drowsiness, dizziness or blurred vision; patients should observe caution before driving, using machinery or performing other tasks requiring mental alertness.

Drug Interactions

Absorption of other oral medications may be decreased during concurrent use with anticholinergics due to decreased gastrointestinal motility and delayed gastric emptying. Drug interactions may occur when anticholinergics are used with the following medications: antacids, antidiarrheals (adsorbent), other anticholinergics, antimyasthenics, cyclopropane, haloperidol, ketoconazole, metoclopramide, opioid (narcotic) analgesics, and potassium chloride.

Pregnancy

Pregnancy Category C. Animal reproduction studies have not been conducted with this product. It is also not known whether this product can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Hyoscyamine crosses the placenta. This product should be given to a pregnant woman only if clearly needed.

Nursing Mothers

This product is excreted in human milk. This product should not be administered to a nursing mother.

Pediatric Use

This product is not recommended for use in children under twelve years of age. Infants and young children are especially susceptible to the toxic effects of anticholinergics. Close supervision is recommended for infants and children with spastic paralysis or brain damage since an increased response to anticholinergics has been reported in these patients and dosage adjustments are often required. When anticholinergics are given to children where the environmental temperature is high, there is a risk of a rapid increase in body temperature because of these medications’ suppression of sweat gland activity. A paradoxical reaction characterized by hyperexcitability may occur in children taking large doses of anticholinergics.

Geriatric Use

Geriatric patients may respond to usual doses of anticholinergics with excitement, agitation, drowsiness, or confusion. Geriatric patients are especially susceptible to the anticholinergic side effects, such as constipation, dryness of mouth, and urinary retention (especially in males). If these side effects occur and continue or are severe, medication should probably be discontinued. Caution is also recommended when anticholinergics are given to geriatric patients, because of the danger of precipitating undiagnosed glaucoma. Memory may become severely impaired in geriatric patients, especially those who already have memory problems, with the continued use of anticholinergics since these drugs block the actions of acetylcholine, which is responsible for many functions of the brain, including memory functions.

ADVERSE REACTIONS

Not all of the following adverse reactions have been reported with hyoscyamine sulfate. The following adverse reactions have been reported for pharmacologically similar drugs with anticholinergic-antispasmodic action. Adverse reactions may include dryness of the mouth, urinary hesitancy and retention; blurred vision; tachycardia; palpitations; mydriasis; cycloplegia; increased ocular tension; loss of taste; headache; nervousness; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; impotence; suppression of lactation; constipation; bloated feeling; allergic reactions or drug idiosyncrasies; urticaria and other dermal manifestations; ataxia; speech disturbance; some degree of mental confusion and/or excitement (especially in elderly persons); and decreased sweating.

OVERDOSAGE

The signs and symptoms of overdose are headache, nausea, vomiting, blurred vision, dilated pupils, hot dry skin, dizziness, dryness of the mouth, difficulty in swallowing and CNS stimulation.

Measures to be taken are immediate lavage of the stomach and injection of physostigmine 0.5 to 2 mg intravenously and repeated as necessary up to a total of 5 mg. Fever may be treated symptomatically (tepid water sponge baths, hypothermic blanket). Excitement to a d degree which demands attention may be managed with sodium thiopental 2% solution given slowly intravenously or chloral hydrate (100- 200 mL of a 2% solution) by rectal infusion. In the event of progression of the curare-like effect to paralysis of the respiratory muscles, artificial respiration should be instituted and maintained until effective respiratory action returns. In rats, the LD50 for hyoscyamine is 375 mg/kg. Hyoscyamine is dialyzable.

DOSAGE AND ADMINISTRATION

Usual dosage: Adults and children over 12 years of age: 1 to 2 tablets orally every 12 hours. Dosage may be adjusted to 1 tablet every 8 hours if needed. Do not exceed 4 tablets in 24 hours.

Tablets should be swallowed whole.

Note: Geriatric patients may be more sensitive to the effects of the usual adult dose.

HOW SUPPLIED

Oscimin SR Tablets are supplied as green, capsule shaped tablets debossed “LL 255” on one side and plain on the opposite side. They are available in bottles of 100 tablets, NDC 68047-255-01.

Storage and Handling

Dispense in a tight, light-resistant container as defined in USP/NF, with a child-resistant closure.

Store at controlled room temperature between 20°-25°C (68°-77°F), see USP Controlled Room Temperature.

KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.

Manufactured for:

Larken Laboratories, Inc.

Canton, MS 39046

Rev. 06/2011   500416

PRINCIPAL DISPLAY PANEL

Figure 2: Container label

OSCIMIN  hyoscyamine sulfate  tablet, extended release

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 68047-255 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYOSCYAMINE SULFATE (HYOSCYAMINE) HYOSCYAMINE SULFATE 0.375 mg

Inactive Ingredients Ingredient Name Strength ANHYDROUS DIBASIC CALCIUM PHOSPHATE   ETHYLCELLULOSE (10 MPA.S)   D&C YELLOW NO. 10   FD&C BLUE NO. 1   LACTOSE MONOHYDRATE   MAGNESIUM STEARATE   CELLULOSE, MICROCRYSTALLINE   STEARIC ACID

Product Characteristics Color GREEN Score no score Shape CAPSULE Size 15mm Flavor Imprint Code LL255 Contains

Packaging # NDC Package Description Multilevel Packaging 1 68047-255-01 100 TABLET In 1 BOTTLE None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Unapproved drug other		08/03/2011

Labeler - Larken Laboratories, Inc. (791043719)

Registrant - Larken Laboratories, Inc. (791043719)

Establishment
Name	Address	ID/FEI	Operations
Sovereign Pharmaceuticals, LLC		623168267	MANUFACTURE

Revised: 08/2011Larken Laboratories, Inc.

More Oscimin SR Tablets resources

• Oscimin SR Tablets Side Effects (in more detail)
• Oscimin SR Tablets Use in Pregnancy & Breastfeeding
• Drug Images
• Oscimin SR Tablets Drug Interactions
• Oscimin SR Tablets Support Group
• 20 Reviews for Oscimin SRs - Add your own review/rating

Compare Oscimin SR Tablets with other medications

• Anesthesia
• Crohn's Disease
• Endoscopy or Radiology Premedication
• Irritable Bowel Syndrome
• Urinary Incontinence

Omevax

Omevax may be available in the countries listed below.

Ingredient matches for Omevax

Omeprazole

Omeprazole is reported as an ingredient of Omevax in the following countries:

• Venezuela

International Drug Name Search